Our main approach was to design new small molecules as BCL-2 inhibitors with potential anti-cancer activity based on literature review and SAR studies, novel benzothiazole-based compounds were designed, synthesized and evaluated for their in vitro BCL-2 inhibitory activity. The gene discussed is BCL2; the disease is cancer.